View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
Sponsored by Aptar Pharma

Nasal Drug Delivery Devices and Pain Management Systems

Free White Paper

Nasal Drug Delivery Devices and Pain Management Systems

By Aptar Pharma

Nasal Drug Delivery Devices and Pain Management Systems

By Aptar Pharma
Enter your details to receive the free paper:

Worth an estimated >2bn in 2009, the nasally administered systemic drugs market has an increasing generics sector, is placing greater emphasis on patient compliance and convenience, and is benefitting from an increasingly ageing population.

In contrast, severe pressure on health care costs is negatively affecting the market.

The Nasal route is beneficial due to its rapid onset of action, it is non-invasive, has good bio-availability, and patients can self-medicate.

Download this free whitepaper to find out more about the current trends in nasal drug delivery, including potential applications of nasal administration, recent additions to the marketplace, drugs soon to be added to the market, challenges and future opportunities, and potential e-device solutions.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology